ММВБ 2 935 0,4%  Nasdaq 8 541 0,7%  Биткойн 8 534 0,4%  USD/RUB 63,5405 -0,6% 
РТС 1 449 0,9%  S&P500 3 120 0,8%  Нефть 63,5 1,7%  EUR/RUB 70,4535 0,0% 
Dow 28 005 0,8%  FTSE100 7 303 0,1%  Золото 1 467 -0,3%  EUR/USD 1,1055 0,0% 

Курс акций Eli Lilly and [ISIN: US5324571083]

купить
продать

Eli Lilly and Co. - Профиль

Eli Lilly and Company занимается исследованием, разработкой, производством и продажей фармацевтической продукции. Производит и распространяет продукты через свои подразделения в США, Пуэрто-Рико и 15 других странах. Ее препараты продаются более чем в 130 странах и используются в лечении неврологических и психических болезней, а также в эндокринологии, онкологии, кардиологии и ветеринарии. В феврале 2012-го компания присоединила непубличную биокомпанию ChemGen Corp. 7 июля 2011-го купила ветеринарный бизнес компании Janssen, принадлежащей Johnson & Johnson.

Акционеры

Название Доля (%)
Lilly Endowment, Inc.12,03
The Vanguard Group, Inc.7,14
PRIMECAP Management Co.4,45
BlackRock Fund Advisors4,31
SSgA Funds Management, Inc.3,93
Wellington Management Co. LLP3,78
T. Rowe Price Associates, Inc. (Investment Management)2,32
State Farm Investment Management Corp.2,05
Capital Research & Management Co. (International Investors)1,66
Geode Capital Management LLC1,26
Fidelity Management & Research Co.1,22
Northern Trust Investments, Inc.(Investment Management)1,14
Norges Bank Investment Management0,94
Dodge & Cox0,91
JPMorgan Investment Management, Inc.0,82

Адрес

Lilly Corporate Center, 46285 Indianapolis
а/я:
Телефон: 13172762000
Факс:
Вэб: http://www.lilly.com

Менеджмент

David A. Ricks, MBA
Chairman, President & Chief Executive Officer
Sidney Taurel, MBA
Chairman-Emeritus
Donald A. Zakrowski
Chief Accounting Officer & Vice President-Finance
Melissa Stapleton Barnes
Chief Ethics & Compliance Officer, Senior VP
Joshua L. Smiley
Chief Financial Officer & Senior Vice President
Aarti S. Shah, PhD
Chief Information Officer & SVP-IT
Robert B. Brown, MBA
Chief Marketing Officer & Senior VP-Marketing
Timothy J. Garnett, MD
Chief Medical Officer & VP-Global Medical
Daniel M. Skovronsky MD, PhD
Chief Scientific Officer & Senior Vice President
Robert Conley, MD
Development Leader-Neuroscience
Karen Walker
Director
Michael J. Harrington
Executive Vice President & General Counsel
Michael Overdorf
Global Brand Development Leader
Kathi P. Seifert
Independent Director
Michael L. Eskew
Independent Director
Jon Erik Fyrwald
Independent Director
William G. Kaelin Jr., MD
Independent Director
Ralph Alvarez
Independent Director
Katherine Baicker, PhD
Independent Director
Jackson Peter Tai, MBA
Independent Director
Jamere Jackson, CPA
Independent Director
Carolyn R. Bertozzi, PhD
Independent Director
Marschall S. Runge MD, PhD
Independent Director
Kevin Hern
Investor Relations Contact
Juan Ricardo Luciano
Lead Independent Director
Terence Rooney, MD
Medical Director-Rheumatoid Arthritis
Sheena Aurora, MD
Medical Fellow & Global Launch Leader
Christi L. Shaw, MBA
President-Bio Medicines & Senior Vice President
Bronwen L. Mantlo
Secretary & Deputy General Counsel
Sherry Martin, MD
Senior Medical Director-Lilly Diabetes
Alfonso G. Zulueta, MBA
Senior VP & President-Lilly International
Myles Oneill
Senior VP & President-Manufacturing Operations
Leigh Ann Pusey
Senior VP-Corporate Affairs & Communications
E. Paul Ahern, PhD
Senior VP-Global API & Dry Manufacturing
Levi A. Garraway MD, PhD
Senior VP-Global Development & Medical Affairs
Stephen F. Fry
Senior VP-Human Resources & Diversity
Enrique A. Conterno, MBA
Senior Vice President
Anne E. White
Senior Vice President
Johna L. Norton
Senior Vice President-Global Quality
Philip L. Johnson
Treasurer & Senior Vice President-Finance
Martin Bott
VP-Corporate Finance & Investment Banking
Carl L. McMillian
VP-Toxicology, Drug Disposition & PKPD
Robert J. Heine MD, PhD
Vice President-Medical Affairs
Nathaniel R. Miles
Vice President-Strategic Initiatives

Добавить или редактировать инструмент